Telomir Pharmaceuticals (NASDAQ: TELO) announced preclinical findings showing that its telomere-elongating drug, Telomir-1, reduced tumor size by app ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

Telomir Pharmaceuticals (TELO) announced on Wednesday preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a prostate ca ...

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

Dream Pairs is ushering in a new era of spring fashion with its highly anticipated Spring 2025 Collection. Designed with ...

Here are five must-do exercises that target the calf muscles effectively, keeping them supple and strong. The standing calf ...

It's a big day in the astrological calendar. The Sun and Neptune are forming a conjunction – the final Pisces pairing of these two planets in our lifetime. It's a cosmic invitation to dream and ...